The two faces of interleukin 10 in human infectious diseases
Resolution of infections depends on the host's ability to mount a protective immune response. However, an exacerbated response to infections may result in deleterious lesions. Consequently, immunoregulatory mechanisms are needed to control immune response and prevent infection-associated lesion...
Gespeichert in:
Veröffentlicht in: | The Lancet infectious diseases 2006-09, Vol.6 (9), p.557-569 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 569 |
---|---|
container_issue | 9 |
container_start_page | 557 |
container_title | The Lancet infectious diseases |
container_volume | 6 |
creator | Mege, Jean-Louis Meghari, Soraya Honstettre, Amélie Capo, Christian Raoult, Didier |
description | Resolution of infections depends on the host's ability to mount a protective immune response. However, an exacerbated response to infections may result in deleterious lesions. Consequently, immunoregulatory mechanisms are needed to control immune response and prevent infection-associated lesions. Interleukin 10 may be a major regulator of innate and adaptive immunity in vitro and in animals, but its role in human infections is still unclear. Review of the published work reveals wide involvement of interleukin 10 in two major features of infectious diseases. On one hand, interleukin 10 prevents the development of immunopathological lesions that result from exacerbated protective immune response to acute and chronic infections. On the other hand, it is critically involved in persistence of bacteria and viruses by interfering with innate and adaptive protective immunity. Moreover, infections induce the expansion of interleukin-10-producing regulatory cells that are involved in protection against allergic diseases. |
doi_str_mv | 10.1016/S1473-3099(06)70577-1 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68781233</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1473309906705771</els_id><sourcerecordid>68781233</sourcerecordid><originalsourceid>FETCH-LOGICAL-c538t-34c7e9b4f3dff92fe654ddf3ba27630a9ae4d76c6d33c25458f776addb4afda93</originalsourceid><addsrcrecordid>eNqFkF1LwzAUhoMoTqc_QSmCohfVpEmTFgSR4RcMvHBehyw5YZldO5NW8d-brYOBN16dD55zeHkQOiH4mmDCb94IEzSluCwvMb8SOBciJTvoIK5Zylgudtd9jwzQYQhzjIkgmO2jAeElJQyLA3Q7mUHSfjeJVRpC0tjE1S34CroPVycExzGZdQtVx8aCbl3ThcS4ACpAOEJ7VlUBjjd1iN4fHyaj53T8-vQyuh-nOqdFm1KmBZRTZqmxtsws8JwZY-lUZYJTrEoFzAiuuaFUZznLCysEV8ZMmbJGlXSILvq_S998dhBauXBBQ1WpGmIeyQtRkIzSCJ79AedN5-uYTWZRGslyUUQo7yHtmxA8WLn0bqH8jyRYrtzKtVu5Eicxl2u3ksS7083zbroAs73ayIzA-QZQQavKelVrF7ZcgbOSixV313MQnX058DJoB7UG43xULE3j_onyC4SYlNg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>201612578</pqid></control><display><type>article</type><title>The two faces of interleukin 10 in human infectious diseases</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><source>ProQuest Central UK/Ireland</source><creator>Mege, Jean-Louis ; Meghari, Soraya ; Honstettre, Amélie ; Capo, Christian ; Raoult, Didier</creator><creatorcontrib>Mege, Jean-Louis ; Meghari, Soraya ; Honstettre, Amélie ; Capo, Christian ; Raoult, Didier</creatorcontrib><description>Resolution of infections depends on the host's ability to mount a protective immune response. However, an exacerbated response to infections may result in deleterious lesions. Consequently, immunoregulatory mechanisms are needed to control immune response and prevent infection-associated lesions. Interleukin 10 may be a major regulator of innate and adaptive immunity in vitro and in animals, but its role in human infections is still unclear. Review of the published work reveals wide involvement of interleukin 10 in two major features of infectious diseases. On one hand, interleukin 10 prevents the development of immunopathological lesions that result from exacerbated protective immune response to acute and chronic infections. On the other hand, it is critically involved in persistence of bacteria and viruses by interfering with innate and adaptive protective immunity. Moreover, infections induce the expansion of interleukin-10-producing regulatory cells that are involved in protection against allergic diseases.</description><identifier>ISSN: 1473-3099</identifier><identifier>EISSN: 1474-4457</identifier><identifier>DOI: 10.1016/S1473-3099(06)70577-1</identifier><identifier>PMID: 16931407</identifier><identifier>CODEN: LANCAO</identifier><language>eng</language><publisher>London: Elsevier Ltd</publisher><subject>Bacterial Infections - immunology ; Biological and medical sciences ; Disease Susceptibility - immunology ; Epidemiology. Vaccinations ; General aspects ; Humans ; Immune response ; Infection - immunology ; Infectious diseases ; Interleukin-10 - chemistry ; Interleukin-10 - physiology ; Lesions ; Medical sciences ; Mycoses - immunology</subject><ispartof>The Lancet infectious diseases, 2006-09, Vol.6 (9), p.557-569</ispartof><rights>2006 Elsevier Ltd</rights><rights>2006 INIST-CNRS</rights><rights>Copyright Elsevier Limited Sep 2006</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c538t-34c7e9b4f3dff92fe654ddf3ba27630a9ae4d76c6d33c25458f776addb4afda93</citedby><cites>FETCH-LOGICAL-c538t-34c7e9b4f3dff92fe654ddf3ba27630a9ae4d76c6d33c25458f776addb4afda93</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/201612578?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,777,781,3537,27905,27906,45976,64364,64366,64368,72218</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18029677$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16931407$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mege, Jean-Louis</creatorcontrib><creatorcontrib>Meghari, Soraya</creatorcontrib><creatorcontrib>Honstettre, Amélie</creatorcontrib><creatorcontrib>Capo, Christian</creatorcontrib><creatorcontrib>Raoult, Didier</creatorcontrib><title>The two faces of interleukin 10 in human infectious diseases</title><title>The Lancet infectious diseases</title><addtitle>Lancet Infect Dis</addtitle><description>Resolution of infections depends on the host's ability to mount a protective immune response. However, an exacerbated response to infections may result in deleterious lesions. Consequently, immunoregulatory mechanisms are needed to control immune response and prevent infection-associated lesions. Interleukin 10 may be a major regulator of innate and adaptive immunity in vitro and in animals, but its role in human infections is still unclear. Review of the published work reveals wide involvement of interleukin 10 in two major features of infectious diseases. On one hand, interleukin 10 prevents the development of immunopathological lesions that result from exacerbated protective immune response to acute and chronic infections. On the other hand, it is critically involved in persistence of bacteria and viruses by interfering with innate and adaptive protective immunity. Moreover, infections induce the expansion of interleukin-10-producing regulatory cells that are involved in protection against allergic diseases.</description><subject>Bacterial Infections - immunology</subject><subject>Biological and medical sciences</subject><subject>Disease Susceptibility - immunology</subject><subject>Epidemiology. Vaccinations</subject><subject>General aspects</subject><subject>Humans</subject><subject>Immune response</subject><subject>Infection - immunology</subject><subject>Infectious diseases</subject><subject>Interleukin-10 - chemistry</subject><subject>Interleukin-10 - physiology</subject><subject>Lesions</subject><subject>Medical sciences</subject><subject>Mycoses - immunology</subject><issn>1473-3099</issn><issn>1474-4457</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNqFkF1LwzAUhoMoTqc_QSmCohfVpEmTFgSR4RcMvHBehyw5YZldO5NW8d-brYOBN16dD55zeHkQOiH4mmDCb94IEzSluCwvMb8SOBciJTvoIK5Zylgudtd9jwzQYQhzjIkgmO2jAeElJQyLA3Q7mUHSfjeJVRpC0tjE1S34CroPVycExzGZdQtVx8aCbl3ThcS4ACpAOEJ7VlUBjjd1iN4fHyaj53T8-vQyuh-nOqdFm1KmBZRTZqmxtsws8JwZY-lUZYJTrEoFzAiuuaFUZznLCysEV8ZMmbJGlXSILvq_S998dhBauXBBQ1WpGmIeyQtRkIzSCJ79AedN5-uYTWZRGslyUUQo7yHtmxA8WLn0bqH8jyRYrtzKtVu5Eicxl2u3ksS7083zbroAs73ayIzA-QZQQavKelVrF7ZcgbOSixV313MQnX058DJoB7UG43xULE3j_onyC4SYlNg</recordid><startdate>20060901</startdate><enddate>20060901</enddate><creator>Mege, Jean-Louis</creator><creator>Meghari, Soraya</creator><creator>Honstettre, Amélie</creator><creator>Capo, Christian</creator><creator>Raoult, Didier</creator><general>Elsevier Ltd</general><general>Lancet Publishing Group</general><general>Elsevier Limited</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TZ</scope><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8C2</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope></search><sort><creationdate>20060901</creationdate><title>The two faces of interleukin 10 in human infectious diseases</title><author>Mege, Jean-Louis ; Meghari, Soraya ; Honstettre, Amélie ; Capo, Christian ; Raoult, Didier</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c538t-34c7e9b4f3dff92fe654ddf3ba27630a9ae4d76c6d33c25458f776addb4afda93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Bacterial Infections - immunology</topic><topic>Biological and medical sciences</topic><topic>Disease Susceptibility - immunology</topic><topic>Epidemiology. Vaccinations</topic><topic>General aspects</topic><topic>Humans</topic><topic>Immune response</topic><topic>Infection - immunology</topic><topic>Infectious diseases</topic><topic>Interleukin-10 - chemistry</topic><topic>Interleukin-10 - physiology</topic><topic>Lesions</topic><topic>Medical sciences</topic><topic>Mycoses - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mege, Jean-Louis</creatorcontrib><creatorcontrib>Meghari, Soraya</creatorcontrib><creatorcontrib>Honstettre, Amélie</creatorcontrib><creatorcontrib>Capo, Christian</creatorcontrib><creatorcontrib>Raoult, Didier</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Pharma and Biotech Premium PRO</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Nursing & Allied Health Database</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Lancet Titles</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><jtitle>The Lancet infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mege, Jean-Louis</au><au>Meghari, Soraya</au><au>Honstettre, Amélie</au><au>Capo, Christian</au><au>Raoult, Didier</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The two faces of interleukin 10 in human infectious diseases</atitle><jtitle>The Lancet infectious diseases</jtitle><addtitle>Lancet Infect Dis</addtitle><date>2006-09-01</date><risdate>2006</risdate><volume>6</volume><issue>9</issue><spage>557</spage><epage>569</epage><pages>557-569</pages><issn>1473-3099</issn><eissn>1474-4457</eissn><coden>LANCAO</coden><abstract>Resolution of infections depends on the host's ability to mount a protective immune response. However, an exacerbated response to infections may result in deleterious lesions. Consequently, immunoregulatory mechanisms are needed to control immune response and prevent infection-associated lesions. Interleukin 10 may be a major regulator of innate and adaptive immunity in vitro and in animals, but its role in human infections is still unclear. Review of the published work reveals wide involvement of interleukin 10 in two major features of infectious diseases. On one hand, interleukin 10 prevents the development of immunopathological lesions that result from exacerbated protective immune response to acute and chronic infections. On the other hand, it is critically involved in persistence of bacteria and viruses by interfering with innate and adaptive protective immunity. Moreover, infections induce the expansion of interleukin-10-producing regulatory cells that are involved in protection against allergic diseases.</abstract><cop>London</cop><pub>Elsevier Ltd</pub><pmid>16931407</pmid><doi>10.1016/S1473-3099(06)70577-1</doi><tpages>13</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1473-3099 |
ispartof | The Lancet infectious diseases, 2006-09, Vol.6 (9), p.557-569 |
issn | 1473-3099 1474-4457 |
language | eng |
recordid | cdi_proquest_miscellaneous_68781233 |
source | MEDLINE; Elsevier ScienceDirect Journals; ProQuest Central UK/Ireland |
subjects | Bacterial Infections - immunology Biological and medical sciences Disease Susceptibility - immunology Epidemiology. Vaccinations General aspects Humans Immune response Infection - immunology Infectious diseases Interleukin-10 - chemistry Interleukin-10 - physiology Lesions Medical sciences Mycoses - immunology |
title | The two faces of interleukin 10 in human infectious diseases |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T05%3A52%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20two%20faces%20of%20interleukin%2010%20in%20human%20infectious%20diseases&rft.jtitle=The%20Lancet%20infectious%20diseases&rft.au=Mege,%20Jean-Louis&rft.date=2006-09-01&rft.volume=6&rft.issue=9&rft.spage=557&rft.epage=569&rft.pages=557-569&rft.issn=1473-3099&rft.eissn=1474-4457&rft.coden=LANCAO&rft_id=info:doi/10.1016/S1473-3099(06)70577-1&rft_dat=%3Cproquest_cross%3E68781233%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=201612578&rft_id=info:pmid/16931407&rft_els_id=S1473309906705771&rfr_iscdi=true |